Cargando…

Evaluation of cardiotoxicity five years after 2D planned, non-simulated, radiation therapy for left breast cancer

INTRODUCTION: Radiation treatment has been associated with radiation induced cardiotoxicity, especially with older, long-outdated, techniques. Such complications include pericarditis, myocardial fibrosis, valvular injury, ischemic heart disease, and myocardial infarction. AIM: To assess the effect o...

Descripción completa

Detalles Bibliográficos
Autores principales: Pistevou-Gompaki, Kyriaki, Hatzitolios, Apostolos, Eleftheriadis, Nikos, Boultoukas, Evaggelos, Ntaios, George, Andronikidis, Ioannis, Tzitzikas, Ioannis
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643115/
https://www.ncbi.nlm.nih.gov/pubmed/19337441
Descripción
Sumario:INTRODUCTION: Radiation treatment has been associated with radiation induced cardiotoxicity, especially with older, long-outdated, techniques. Such complications include pericarditis, myocardial fibrosis, valvular injury, ischemic heart disease, and myocardial infarction. AIM: To assess the effect of outdated breast radiation therapy (RT) – using a diagnostic CT scanner in the absence of a CT simulator – on cardiac function in women with stage II left breast cancer. PATIENTS AND METHODS: Sixty-two women under 65 with stage II left breast cancer who received post-operative RT using a diagnostic computed tomography scanner were studied between 1997 and 2001. Participants underwent a clinical interview, ECG, and echocardiography before and 6 months and 5 years after RT. RESULTS: There was no serious cardiotoxicity at 6 months and 5 years after radiotherapy. A 23% increase in hypertensive patients, and a slight decrease (2.3%) in ejection fraction was observed after 5 years, with 3 patients (5%) developing abnormalities. Two patients presented abnormal electrocardiographic findings within 6 months of RT. CONCLUSION: Our study showed that RT for left breast cancer was not associated with significant alteration in heart morbidity or mortality within 5 years of treatment, despite the lack of a simulator.